8225 Stock Overview
China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People’s Republic of China.
China Health Group Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||HK$0.29|
|52 Week High||HK$0.51|
|52 Week Low||HK$0.26|
|1 Month Change||-1.67%|
|3 Month Change||-7.81%|
|1 Year Change||-39.18%|
|3 Year Change||158.77%|
|5 Year Change||99.32%|
|Change since IPO||-28.05%|
Recent News & Updates
|8225||HK Life Sciences||HK Market|
Return vs Industry: 8225 exceeded the Hong Kong Life Sciences industry which returned -59.9% over the past year.
Return vs Market: 8225 underperformed the Hong Kong Market which returned -25% over the past year.
|8225 Average Weekly Movement||7.2%|
|Life Sciences Industry Average Movement||7.0%|
|Market Average Movement||6.3%|
|10% most volatile stocks in HK Market||12.7%|
|10% least volatile stocks in HK Market||3.1%|
Stable Share Price: 8225 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: 8225's weekly volatility (7%) has been stable over the past year.
About the Company
China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People’s Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; medical science liaisons; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies.
China Health Group Inc. Fundamentals Summary
|8225 fundamental statistics|
Is 8225 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|8225 income statement (TTM)|
|Cost of Revenue||CN¥11.17m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.03|
|Net Profit Margin||44.66%|
How did 8225 perform over the long term?See historical performance and comparison